The Afrezza Shortage: Where Things Stand in 2026

If you depend on the Afrezza 180 Titration Pack- 60, 60, 60 for your diabetes management, you've probably noticed how difficult it can be to find. Reports of limited availability have been circulating for months, and patients across the country are asking the same question: Is Afrezza in shortage?

Here's what we know right now.

Is Afrezza Still Hard to Find?

Yes. While MannKind Corporation has not officially declared a nationwide shortage, many patients report difficulty filling their Afrezza prescriptions at local pharmacies. The problem isn't that Afrezza has been discontinued — it hasn't. The issue is a combination of limited distribution, low pharmacy stocking, and insurance-related barriers that make it functionally scarce in many areas.

The FDA's drug shortage database may not always list Afrezza, because the supply challenges tend to be localized rather than total. But for the patient standing at the pharmacy counter, the result is the same: you can't get your medication.

Why Is Afrezza Hard to Find?

Several factors contribute to the ongoing availability issues:

• Single manufacturer: MannKind Corporation is the only company that makes Afrezza. There's no generic alternative and no second supplier to pick up slack if production slows.
• Low pharmacy demand: Because Afrezza is a niche product, most pharmacies don't stock it. They'd rather use shelf space for medications they sell every day.
• Insurance hurdles: Prior authorization requirements and specialty tier placement mean fewer patients fill Afrezza prescriptions, which further reduces pharmacy incentive to stock it.
• Specialty distribution: Afrezza often flows through specialty pharmacy channels rather than standard wholesale distribution, limiting where it shows up.

For a deeper dive, read our article on why Afrezza is so hard to find.

How Much Does Afrezza Cost in 2026?

The average retail price for Afrezza without insurance is approximately $550 to $650 per prescription. The exact price varies by pharmacy and the specific pack you're filling.

With insurance, your cost depends on your plan's formulary and tier placement. Many patients face copays of $50 to $150 or more, even with coverage. If cost is a barrier, check out our guide on how to save money on Afrezza.

Are There New Options for Patients?

While no new inhaled insulin has entered the market, there are more tools available to help patients access Afrezza:

• MannKind's AfrezzaAssist program offers co-pay assistance, access support, and help finding pharmacies that carry the product. Visit afrezza.com/savings-program to enroll.
• Discount card programs like SingleCare may reduce the cash price at participating pharmacies.
• Medfinder lets you search for Afrezza availability at pharmacies near you in real time.

How to Find Afrezza Right Now

Here's a step-by-step approach:

1. Search Medfinder for the Afrezza 180 Titration Pack to see which pharmacies near you have it in stock.
2. Call specialty pharmacies in your area — they're more likely to stock it or be able to get it quickly.
3. Contact your doctor's office. Endocrinologists often know which local pharmacies carry Afrezza regularly.
4. Consider mail-order. Some specialty mail-order pharmacies can ship Afrezza directly to you.

For more detailed strategies, see our guide on how to find Afrezza in stock near you.

Final Thoughts

The Afrezza shortage isn't a simple on-or-off situation. The medication is still being made, but systemic issues — from manufacturing concentration to insurance red tape — make it genuinely hard to access for many patients.

Stay proactive. Use tools like Medfinder, keep in touch with your doctor, and have a backup plan in case you need a temporary alternative. Your diabetes management is too important to leave to chance.